Agilon Health (NYSE:AGL) Shares Down 5.2% on Analyst Downgrade

Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s stock price was down 5.2% during trading on Wednesday after Evercore ISI lowered their price target on the stock from $5.00 to $3.00. Evercore ISI currently has an in-line rating on the stock. Agilon Health traded as low as $2.26 and last traded at $2.27. Approximately 412,174 shares traded hands during trading, a decline of 92% from the average daily volume of 5,292,059 shares. The stock had previously closed at $2.39.

AGL has been the topic of several other reports. Robert W. Baird cut their target price on Agilon Health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Needham & Company LLC reaffirmed a "hold" rating on shares of Agilon Health in a research report on Friday, March 21st. The Goldman Sachs Group lifted their target price on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Citigroup raised Agilon Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $3.25 to $5.00 in a research report on Friday, April 25th. Finally, Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and lifted their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $4.71.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AGL. Nisa Investment Advisors LLC boosted its position in Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after acquiring an additional 6,783 shares during the period. Gabelli Funds LLC acquired a new position in Agilon Health during the 1st quarter worth $48,000. Signaturefd LLC boosted its position in Agilon Health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after acquiring an additional 8,467 shares during the period. Ridgecrest Wealth Partners LLC acquired a new position in Agilon Health during the 1st quarter worth $65,000. Finally, Pallas Capital Advisors LLC acquired a new position in Agilon Health during the 1st quarter worth $66,000.

Agilon Health Trading Up 1.1%

The stock has a 50-day simple moving average of $2.51 and a 200-day simple moving average of $3.22. The company has a market cap of $958.29 million, a price-to-earnings ratio of -3.92 and a beta of 0.16.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The company's revenue was down 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.02) earnings per share. As a group, research analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.